Web Results



Imatinib (INN), marketed by Novartis as Gleevec or Glivec investigational name STI-571, is a tyrosine-kinase inhibitor used in the treatment of multiple cancers, ...

Imatinib: MedlinePlus Drug Information - National Library of Medicine


Imatinib is used to treat certain types of leukemia (cancer that begins in the white blood cells) and other cancers of the blood cells. Imatinib is also used to treat ...

Imatinib: Indications, Side Effects, Warnings - Drugs.com


Easy to read patient leaflet for imatinib. Includes indications, proper use, special instructions, precautions, and possible side effects.

Imatinib (Glivec) | Cancer Research UK


Feb 11, 2015 ... Read about the cancer treatment drug imatinib, otherwise known as Glivec, including what it is, how it works and possible side effects.

imatinib, Gleevec: Drug Facts, Side Effects and Dosing - MedicineNet


May 18, 2015 ... Consumer information about the medication imatinib (Gleevec), prescribed for the treatment of Leukemia. Information includes side effects, ...

Treatment for KIT+ GIST & Ph+ CML | Gleevec (imatinib mesylate)


Learn how GLEEVEC works to treat certain adult patients with KIT+ gastrointestinal stromal tumors (GIST). Click here to view Important Safety Information.

imatinib oral : Uses, Side Effects, Interactions, Pictures, Warnings ...


Find patient medical information for imatinib oral on WebMD including its uses, side effects and safety, interactions, pictures, warnings and user ratings.

Prescribing Information - Novartis


GLEEVEC safely and effectively. See full prescribing information for. GLEEVEC. GLEEVEC® (imatinib mesylate) tablets for oral use. Initial U.S. Approval: 2001.

Imatinib Mesylate - Drug Information - Chemocare


(eye-MAT-eh-nib mez-i-late). Trade name: Gleevec<sup>TM</sup> Other names: STI-571. Gleevec is the trade name for the generic drug name Imatinib Mesylate. STI-571 is ...

Imatinib Mesylate - U.S. Food and Drug Administration


Aug 26, 2013 ... Gleevec (Imatinib Mesylate) Questions and Answers. What is Gleevec? Gleevec is a new type of cancer drug – the first of its kind developed to ...

More Info

Imatinib Mesylate - National Cancer Institute


This page contains brief information about imatinib mesylate and a collection of links to more information about the use of this drug, research results, and ...

Gleevec (Imatinib Mesylate) Drug Information: Description, User ...


Imatinib is a small molecule kinase inhibitor. Gleevec film-coated tablets contain imatinib mesylate equivalent to 100 mg or 400 mg of imatinib free base. Imatinib  ...

DrugBank: Imatinib


It is currently marketed by Novartis as Gleevec (USA) or Glivec (Europe/Australia) as its mesylate salt, imatinib mesilate (INN). It is occasionally referred to as ...